Cost of disorders of the brain in Europe 2010

Gustavsson, Anders, Svensson, Mikael, Jacobi, Frank, Allgulander, Christer, Alonso, Jordi, Beghi, Ettore, Dodel, Richard, Ekman, Mattias +35 more·2011·European Neuropsychopharmacology

Cited by (1,008)

Items 601–700 of 1,008

  1. The cost burden of problematic internet usage
    Hans‐Jürgen Rumpf, Tobias Effertz, Christian Montag · 2022 · Current Opinion in Behavioral Sciences
  2. The cost of mental disorders in Denmark: a register-based study
    Maria Klitgaard Christensen, John Joseph McGrath, Natalie C. Momen, Harvey Whiteford, Nanna Weye, Esben Agerbo, Carsten Bøcker Pedersen, Preben Bo Mortensen, Oleguer Plana‐Ripoll, Kim Moesgaard Iburg · 2022 · npj Mental Health Research
  3. Treatment received and treatment adequacy of depressive disorders among young adults in Finland
    Teija Kasteenpohja, MAURI J. MARTTUNEN, Terhi Aalto‐Setälä, Jonna Perälä, Samuli I. Saarni, Jaana Suvisaari · 2015 · BMC Psychiatry
  4. Identification and location of hot and cold spots of treated prevalence of depression in Catalonia (Spain)
    José Alberto Salinas-Pérez, CARLOS RAMÓN GARCÍA-ALONSO, Cristina Molina-Parrilla, Esther Jordà, Luis Salvador‐Carulla · 2012 · International Journal of Health Geographics
  5. What does the developing brain tell us about neural diseases?
    Esther T. Stoeckli · 2012 · European Journal of Neuroscience
  6. Procesos cognitivos y regulación emocional: aportes desde una aproximación psicoevolucionista
    Leonardo Adrián Medrano, Roger Muñoz‐Navarro, Antonio Cano Vindel · 2016 · Ansiedad y Estrés
  7. Avoiding at all costs? An exploration of avoidance costs in a novel Virtual Reality procedure
    Anke Lemmens, Tom Smeets, Tom Beckers, Pauline Dibbets · 2021 · Learning and Motivation
  8. Evaluation of deep learning-based depression detection using medical claims data
    Markus Bertl, Nzamba Bignoumba, Peeter Ross, Sadok Ben Yahia, Dirk Draheim · 2023 · Artificial Intelligence in Medicine
  9. Prediction and prevention of psychosis: current progress and future tasks
    Stephan Ruhrmann, Frauke Schultze‐Lutter, Stefanie J. Schmidt, Nathalie Kaiser, Joachim Klosterkötter · 2014 · European Archives of Psychiatry and Clinical Neuroscience
  10. Chances and risks of predicting psychosis
    Stephan Ruhrmann, Joachim Klosterkötter, Mitja Bodatsch, Alexandra S.C. Nikolaides, Dominika Julkowski, Desire Hilboll, Frauke Schultz-Lutter · 2012 · European Archives of Psychiatry and Clinical Neuroscience
  11. Economic impacts of environmentally attributable childhood health outcomes in the European Union
    Emily Suzanne Bartlett, Leonardo Trasande · 2013 · European Journal of Public Health
  12. Validation de la traduction française d’un questionnaire court de dépression de Beck (BDI-FS-Fr)
    Muaweah Ahmad Alsaleh, Romain Lebreuilly · 2017 · Annales Médico-psychologiques revue psychiatrique
  13. Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test
    Filipe Marques Gonçalves, Vivian Binder Neis, Débora Kurrle Rieger, Tanara Vieira Peres, Mark William Lopes, Isabella A. Heinrich, Ana Paula Costa, Ana Lúcia S. Rodrigues, Manuella Pinto Kaster, Rodrigo Bainy Leal · 2017 · Journal of Neural Transmission
  14. Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland
    Lars Tönges, Dirk Bartig, Siegfried Muhlack, Wolfgang H. Jost, Ralf Gold, Christos Krogias · 2018 · Der Nervenarzt
  15. Changes in brain glucose metabolism and connectivity in somatoform disorders: an 18F-FDG PET study
    Qi Huang, Shuhua Ren, Donglang Jiang, Yihui Guan, Fang Xie, Daliang Sun, Fengchun Hua · 2019 · European Archives of Psychiatry and Clinical Neuroscience
  16. Regular employment for people with mental illness – An evaluation of the individual placement and support programme
    Tor Helge Holmås, Karin Monstad, Silje Endresen Rème · 2021 · Social Science & Medicine
  17. Neuroplastin in Neuropsychiatric Diseases
    Xiao Lin, Yi Chu Liang, Rodrigo Herrera‐Molina, Dirk Montag · 2021 · Genes
  18. Problematic Smartphone Use Influences the Relationship Between Experiential Avoidance and Anxiety
    Julia Y. Gorday, Joseph R. Bardeen · 2021 · Cyberpsychology Behavior and Social Networking
  19. Long-term cost-effectiveness of group unified protocol in the Spanish public mental health system
    Óscar Péris-Baquero, Julián D. Moreno-Villamizar, Jorge Osma · 2022 · Current Psychology
  20. Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design
    Naomi Anne Fineberg, Luca Pellegrini, Aaron Clarke, Uday Perera, Lynne M. Drummond, Umberto Albert, Keith R. Laws · 2022 · Comprehensive Psychiatry
  21. The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions
    Alberto Raggi, Matilde Leonardi, Venusia Covelli, Davide Sattin, Chiara Scaratti, Silvia Schiavolin, Michelle Willems, Paolo Meucci · 2015 · Neurorehabilitation
  22. Theoretical and practical applications of the intracerebroventricular route for CSF sampling and drug administration in CNS drug discovery research: A mini review
    Andy Kuo, Maree Therese Smith · 2014 · Journal of Neuroscience Methods
  23. Cost-effectiveness analysis of a collaborative care programme for depression in primary care
    Enric Aragonès, Germán López-Cortacans, Eduardo Sánchez, Josep Lluís Piñol, Antònia Caballero, Luis Salvador‐Carulla, Juan Manuel Cabasés Hita · 2014 · Journal of Affective Disorders
  24. Comprehensive Cost of Illness of Three Major Diseases in Japan
    Kunichika Matsumoto, Simpei Hanaoka, Yinghui Wu, Tomonori Hasegawa · 2017 · Journal of Stroke and Cerebrovascular Diseases
  25. Analyzing Medical Emergency Processes with Process Mining: The Stroke Case
    Carlos Fernández-Llatas, Gema Ibáñez-Sánchez, Angeles Celda, Jesús Mandingorra, Lucia Aparici-Tortajada, Antonio Martínez-Millana, Jorge Muñoz-Gama, Marcos Sepúlveda, Eric Rojas, Víctor Galvez-Yanjari et al. · 2019 · Lecture notes in business information processing
  26. Towards selective CNS PET Imaging of the 5-HT7 Receptor System: Past, Present and Future.
    E. T. L'Estrade, M. Erlandsson, Fraser G. Edgar, T. Ohlsson, G. Knudsen, M. Herth · 2020 · Neuropharmacology
  27. Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis
    Christoph J. Wagner, Florian Gerhard Metzger, Christoph Sievers, Ursula Marschall, Helmut L’Hoest, Björn Stollenwerk, Stephanie Stock · 2016 · Journal of Affective Disorders
  28. Alterações mentais em trabalhadores de unidades de terapia intensiva
    Andressa Fernanda Silva, Maria Lúcia do Carmo Cruz Robazzi · 2019 · SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português)
  29. Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments
    Tina Habota, Anca‐Larisa Sandu, Gordon D. Waiter, Christopher J. McNeil, J. Douglas Steele, Jennifer A. Macfarlane, Heather Clare Whalley, Ruth Valentine, Dawn Younie, Nichola Crouch et al. · 2021 · Wellcome Open Research
  30. Virtual reality for neurorehabilitation: A bibliometric analysis of knowledge structure and theme trends
    Qifan Guo, Lin He, Wei Cheng Su, Huixin Tan, Lianyi Han, Chenfan Gui, Yi Chen, Hanhong Jiang, Qiang Gao · 2022 · Frontiers in Public Health
  31. Paracelsus 10,000: An Observational Cohort Study About the Health Status of the Population of Salzburg, Austria. Rationale, Objectives and Study Design
    Vanessa Frey, Patrick Benjamin Langthaler, Emanuel Raphaelis, Susanne Ring‐Dimitriou, Ludmilla Kedenko, Elmar Stephan Aigner, Jennifer Martinz, Isabella Gostner, Arne Cornelius Bathke, Reinhold Fartacek et al. · 2023 · Paracelsus Proceedings of Experimental Medicine
  32. La carga de la enfermedad en España 2010: trastornos neurológicos, mentales y re: trastornos neurológicos, mentales y relacionados con el consumo de sustancias
    Elvira Lara, Noé Garín, Alize J Ferrari, Stefanos Tyrovolas, Beatriz Olaya, Lídia Sànchez-Riera, Harvey Whiteford, Josep Maria Haro · 2014 · Revista de Psiquiatría y Salud Mental
  33. The neurobiology of eating disorders—a clinical perspective
    Yvonne von Hausswolff‐Juhlin, Samantha Jane Brooks, M. Larsson · 2014 · Acta Psychiatrica Scandinavica
  34. Reduzierung alkoholbedingter Mortalität durch Behandlung der Alkoholabhängigkeit
    Jürgen T. Rehm, Maximilien X. Rehm, Kevin David Shield, Gerrit Eduard Gmel, Ulrich Frick, Karl F Mann · 2014 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
  35. Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job)
    Alberto Raggi, Ambra Mara Giovannetti, Silvia Schiavolin, Paolo Agostino Confalonieri, Laura Brambilla, Greta Brenna, Francesca Cortese, Venusia Covelli, Rita Frangiamore, Marco Elvio Manlio Moscatelli et al. · 2015 · Acta Neurologica Scandinavica
  36. Estimating prevalence and burden of major disorders of the brain in Nepal: cultural, geographic, logistic and philosophical issues of methodology
    Ajay Risal, Kedar Manandhar, Timothy J. Steiner, Are Holen, Rajendra Koju, Mattias Linde · 2014 · The Journal of Headache and Pain
  37. The clinical effectiveness of concise cognitive behavioral therapy with or without pharmacotherapy for depressive and anxiety disorders; a pragmatic randomized controlled equivalence trial in clinical practice
    Denise Meuldijk, Ingrid V. E. Carlier, Irene M. van Vliet, Tineke van Veen, Ron Wolterbeek, Albert M. van Hemert, Frans G. Zitman · 2016 · Contemporary Clinical Trials
  38. Retos de la investigación psicológica en salud mental
    Miquel Tortella‐Feliu, Rosa Baños, Neus Barrantes‐Vidal, Cristina Botella, Fernando Fernández‐Aranda, Javier García‐Campayo, Azucena García‐Palacios, Gonzalo Hervás, Susana Jiménez‐Múrcia, Ignacio Montorio et al. · 2016 · Clínica y Salud
  39. Time for change? A national audit on bereavement care in intensive care units
    Marcia A. Berry, Emily Brink, Victoria Metaxa · 2016 · Journal of the Intensive Care Society
  40. National funding for mental health research in Finland, France, Spain and the United Kingdom
    Jean‐Baptiste Hazo, Coralie Gandré, Marion Leboyer, Carla Obradors‐Tarragó, Stefano R. Belli, David McDaid, A‐La Park, María Victoria Maliandi, Kristian Wahlbeck, Til Wykes et al. · 2017 · European Neuropsychopharmacology
  41. Associations of self-reported physical activity and anxiety symptoms and status among 7,874 Irish adults across harmonised datasets: a DEDIPAC-study
    Cillian P. Mc Dowell, Angela Carlin, Laura Capranica, Christina B. Dillon, Janas M. Harrington, Jeroen Lakerveld, Anne Loyen, Fiona Chun Man Ling, Johannes Brug, Ciarán MacDonncha et al. · 2020 · BMC Public Health
  42. Mapping out the philosophical questions of AI and clinical practice in diagnosing and treating mental disorders
    Susanne Uusitalo, Jarno Tuominen, Valtteri Arstila · 2020 · Journal of Evaluation in Clinical Practice
  43. Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study
    Antonio Tundo, Sophia Betrò, Marica Iommi, Rocco de Filippis · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  44. Prevalence of Mental Health Problems and Factors Associated with Psychological Distress in Mountain Exercisers: A Cross-Sectional Study in Austria
    Martin Niedermeier, Arnulf Josef Hartl, Martin Kopp · 2017 · Frontiers in Psychology
  45. Epidemiologie psychischer Störungen
    Frank Jacobi, Manuel Becker, Susanne Müllender, Julia Bretschneider, Julia Thom, Manfred Maximilian Fichter · 2017 · Springer eBooks
  46. Strategies to accelerate diagnosis of primary brain tumors at the primary–secondary care interface in children and adults
    David A. Walker, William Trevor Hamilton, Fiona Mary Walter, Colin Watts · 2013 · CNS Oncology
  47. Acupuncture to Promote Recovery of Disorder of Consciousness after Traumatic Brain Injury: A Systematic Review and Meta-Analysis
    Li Ping Tan, Liling Zeng, Ning Wang, Meijun Deng, Yinshi Chen, Tianyi Ma, Luhan Zhang, Zhenhua Xu · 2019 · Evidence-based Complementary and Alternative Medicine
  48. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action
    Mirko Manchia, Eduard Vieta, Olav Bjerkehagen Smeland, Cara M. Altimus, Andreas Bechdolf, Frank Bellivier, Veerle Bergink, Andrea M. Fagiolini, John Richard Geddes, Tomáš Hájek et al. · 2020 · European Neuropsychopharmacology
  49. Economic Burden of Stroke in Iran: A Population-Based Study.
    M. Movahed, S. H. Barghazan, Amin Adel, A. Rezapour · 2021 · Value in Health Regional Issues
  50. The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
    Marlena van Munster, Johanne Stümpel, Franziska Thieken, Florin Ratajczak, Olivier Rascol, Margherita Fabbri, Timo Clemens, Katarzyna Czabanowska, Tiago Mestre, David José Pedrosa · 2022 · Journal of Parkinson s Disease
  51. Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
    Andrzej Pilc, Agata Machaczka, Paweł Kawalec, Jodi L. Smith, Jeffrey M. Witkin · 2022 · Expert Opinion on Drug Discovery
  52. The social costs of pesticide use in France
    Christophe Alliot, Delphine Mc Adams-Marin, Diana Borniotto, Philippe Vincent Baret · 2022 · Frontiers in Sustainable Food Systems
  53. Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
    Marie Mennesson, Jean‐Michel Revest · 2023 · International Journal of Molecular Sciences
  54. Life Balance – a mindfulness-based mental health promotion program: conceptualization, implementation, compliance and user satisfaction in a field setting
    Lisa Lyssenko, G. Müller, Nikolaus Kleindienst, Christian G. Schmahl, Thomas Berger, Georg H. Eifert, Alexander Kölle, Siegmar Nesch, Jutta Ommer-Hohl, Michael Wenner et al. · 2015 · BMC Public Health
  55. The burden of disease in patients eligible for mentalization-based treatment (MBT): quality of life and costs
    Elisabeth M. P. Laurenssen, Hester V. Eeren, M. Kikkert, J. Peen, D. Westra, J. Dekker, J. Busschbach · 2016 · Health and Quality of Life Outcomes
  56. Risk of stroke after bereavement-a systematic literature review
    Filip Aalbaek, Simon Graff, Mogens Vestergaard · 2017 · Acta Neurologica Scandinavica
  57. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study
    Markus Dold, Lucie Bartova, Alexander Kautzky, Daniel Souery, Julien Mendlewicz, Alessandro Serretti, Stefano Porcelli, Joseph Zohar, Stuart Montgomery, Siegfried F. Kasper · 2017 · European Neuropsychopharmacology
  58. Argon attenuates the emergence of secondary injury after traumatic brain injury within a 2-hour incubation period compared to desflurane: an in vitro study
    L. Grüßer, Rosmarie Blaumeiser-Debarry, Matthias Krings, Benedikt Kremer, A. Höllig, R. Rossaint, M. Coburn · 2017 · Medical Gas Research
  59. Cost-of-treatment of clinically stable severe mental lilnesses in India
    Siddharth Sarkar, Kaliaperumal Mathan, Sreekanth Sakey, Subahani Shaik, Karthick Subramanian, Shivanand Kattimani · 2017 · Indian Journal of Social Psychiatry
  60. Predictors of return to work after stroke: a prospective, observational cohort study with 6 months follow-up
    Lucas Rodrigues Nascimento, Aline Alvim Scianni, Louise Ada, Marcela O. Fantauzzi, Tânia Lúcia Hirochi, Luci Fuscaldi Teixeira‐Salmela · 2019 · Disability and Rehabilitation
  61. Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in Sweden
    Hanna Gyllensten, Andrius Kavaliūnas, Chantelle Murley, Kristina A. E. Alexanderson, Jan A. Hillert, Petter Tinghög, Emilie Friberg · 2019 · Multiple Sclerosis Journal - Experimental Translational and Clinical
  62. The Effect of Adaptive Sports on Individuals with Acquired Neurological Disabilities and Its Role in Rehabilitation: A Systematic Review
    Louise Declerck, Jean‐François Kaux, Marc Vanderthommen, Thierry M. Lejeune, Gaëtan G. Stoquart · 2019 · Current Sports Medicine Reports
  63. Urbanicity mental costs valuation: a review and urban-societal planning consideration
    Luca S. D’Acci · 2020 · Mind & Society
  64. How much is the cost of multiple sclerosis--systematic literature review.
    Katarzyna Kolasa · 2013 · PubMed
  65. Pharmacological considerations in the use of stiripentol for the treatment of epilepsy
    Alberto Verrotti, Giovanni Prezioso, Stefano Stagi, Maria Chiara Paolino, Pasquale Parisi · 2016 · Expert Opinion on Drug Metabolism & Toxicology
  66. Cost‐of‐illness of melanoma in Europe – a modelling approach
    Magdalene Krensel, I. Schäfer, Matthias Augustin · 2019 · Journal of the European Academy of Dermatology and Venereology
  67. Effects of a Online Brief Modified Mindfulness-Based Stress Reduction Therapy for Anxiety among Chinese Adults: A Randomized Clinical Trial
    Wang, Minghuan, Zhang, Han, Zhang, Xiaofan, Zhao, Qian, Chen, Jing, Hu, Caihong, Feng, Renjie, Liu, Denghua, Fu, Peicai, Zhang, Chenyan et al. · 2023 · Journal of Psychiatric Research
  68. ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals
    Sandra Tillmann, Vitor Silva Pereira, Nico Liebenberg, Anne Karina Christensen, Gregers Wegener · 2017 · PLoS ONE
  69. Pavlovian-to-instrumental transfer in subclinical obsessive–compulsive disorder
    Angelos‐Miltiadis Krypotos, Iris M. Engelhard · 2020 · Journal of Experimental Psychopathology
  70. Neural adaptation of cingulate and insular activity during delayed fear extinction: A replicable pattern across assessment sites and repeated measurements
    Isabelle C. Ridderbusch, Adrian Wroblewski, Yunbo Yang, Jan Richter, Maike Hollandt, Alfons O. Hamm, Hans‐Ulrich Wïttchen, Andreas Ströhle, Volker Arolt, Jürgen Margraf et al. · 2021 · NeuroImage
  71. The economic burden of mental disorders among adults in Singapore: evidence from the 2016 Singapore Mental Health Study
    Edimansyah Abdin, Siow Ann Chong, Vithiya Ragu, Janhavi Ajit Vaingankar, Saleha Shafie, Swapna Kamal Verma, Ganga Ganesan, Kelvin Bryan Tan, Derrick Heng, Mythily Subramaniam · 2021 · Journal of Mental Health
  72. Regression-Based Normative Data for Independent and Cognitively Active Spanish Older Adults: Free and Cued Selective Reminding Test, Rey–Osterrieth Complex Figure Test and Judgement of Line Orientation
    Eva Calderón-Rubio, Javier Oltra‐Cucarella, Beatriz Bonete-López, Clara Iñesta, Esther Sitgés Maciá · 2021 · International Journal of Environmental Research and Public Health
  73. Impact of mental disorders during education on work participation: a register-based longitudinal study on young adults with 10 years follow-up
    Fabio Porru, Merel Schuring, Witte J.G. Hoogendijk, Alex Burdorf, Suzan JW Robroek · 2023 · Journal of Epidemiology & Community Health
  74. Integrierte Versorgung für erst- und mehrfacherkrankte Patienten mit schweren psychotischen Erkrankungen
    Martin Lambert, Daniel Schöttle, Friederike Ruppelt, Daniel Lüdecke, Gizem Sarikaya, Michael Schulte‐Markwort, Jürgen Gallinat, Anne Karow · 2015 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  75. Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache
    Sarah Cargnin, Michele Viana, Grazia Sances, Marika Bianchi, Natascia Ghiotto, Cristina Tassorelli, Giuseppe Nappi, Pier Luigi Canonico, Armando A. Genazzani, Salvatore Terrazzino · 2014 · European Journal of Clinical Pharmacology
  76. Multimodal neurophysiological evaluation of primary progressive multiple sclerosis – An increasingly valid biomarker, with limits
    Luke Canham, Nicholas Kane, Agyepong Oware, P. Walsh, Kelly Blake, Kirsty E.A. Inglis, Jenny Homewood, Jonathan Witherick, Howard J. Faulkner, Paul White et al. · 2015 · Multiple Sclerosis and Related Disorders
  77. Costs of informal care in a sample of German geriatric stroke survivors
    D. Albrecht, Tanja Wollensak, C. Ernst, C. Becker, M. Hautzinger, K. Pfeiffer · 2015 · European Journal of Ageing
  78. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial
    Febe E. van der Flier, C. Kwee, Daniëlle C. Cath, Neeltje M. Batelaan, Lucianne Groenink, Puck Duits, Date Claudius van der Veen, Anton J.L.M. van Balkom, Johanna M.P. Baas · 2019 · BMC Psychiatry
  79. Effects of Presleep Cognitive Intrusions on Subjective Sleep and Next-Day Cognitive Performance in Insomnia
    Andrea Ballesio, Valerio Ghezzi, Mariacarolina Vacca, Cristina Ottaviani, Caterina Lombardo · 2019 · Behavior Therapy
  80. Alcohol use and its consequences in the Czech Republic
    Viktor Mravčík, Pavla Chomynová, Blanka Nechanská, Tereza Černíková, Ladislav Csémy · 2019 · Central European Journal of Public Health
  81. Light my fire but don’t choke on the smoke: Wellbeing and pollution from fireplace use in Sweden
    Bodil S. A. Karlsson, Maria Håkansson, Jonas Sjöblom, Henrik Ström · 2020 · Energy Research & Social Science
  82. Psychiatry training in 42 European countries: A comparative analysis
    Franziska Baessler, Ali Zafar, Thomas Gargot, Mariana Pinto da Costa, Ewelina Maria Biskup, Livia De Picker, Katja Koelkebeck, Florian Riese, Howard Ryland, Olga Kazakova et al. · 2021 · European Neuropsychopharmacology
  83. New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary
    Márta Péntek, Gisela Kobelt, Jenny Berg, Daniela Capsa, Johan Dalén, Zita Bíró, Klotild Mátyás, Sámuel Komoly, The European Multiple Sclerosis Platform · 2017 · Multiple Sclerosis Journal
  84. Digital Dementia Registry Bavaria—digiDEM Bayern: study protocol for a multicentre, prospective, longitudinal register study
    Nikolas Dietzel, Lara Kürten, Linda Karrer, Michael Reichold, Laura Köhler, Andreas Nagel, Christina Chmelirsch, Kathrin Seebahn, Markus Hladik, Sebastian Meuer et al. · 2021 · BMJ Open
  85. Resource Utilization of Patients with Parkinson’s Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study
    Christopher Kruse, Sabrina Kretschmer, Anna Luísa Lipinski, Malte Verheyen, David Mengel, Monika Balzer‐Geldsetzer, Stefan Lorenzl, Carmen Richinger, Christian Schmotz, Lars Tönges et al. · 2021 · PharmacoEconomics
  86. Neural Processing of Cognitive Control in an Emotionally Neutral Context in Anxiety Patients
    Nicola König, Sarah Steber, Anna Borowski, Harald Rudolf Bliem, Sonja Rossi · 2021 · Brain Sciences
  87. Unraveling schizophrenia replicable functional connectivity disruption patterns across sites
    Xiaotong Du, Xiaotong Wei, Hao Ding, Ying Yu, Yingying Xie, Yi Ji, Yu Zhang, Chao Chai, Meng Liang, Jie Li et al. · 2022 · Human Brain Mapping
  88. The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis
    Sandra Lira Bastos de Magalhaes, Maura Pugliatti, Ilaria Casetta, Jelena S. Drulovic, Enrico Granieri, Trygve Holmøy, Margitta T. Kampman, Anne‐Marie Landtblom, Klaus Lauer, Kjell‐Morten Myhr et al. · 2015 · Neuroepidemiology
  89. Estimating the prevalence and burden of major disorders of the brain in Nepal: methodology of a nationwide population-based study
    Kedar Manandhar, Ajay Risal, Timothy J. Steiner, Are Holen, Rajendra Koju, Mattias Linde · 2014 · The Journal of Headache and Pain
  90. Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using 18F-GE-179 and 18F-GE-194 Autoradiography
    Francisco R. Lopez‐Picon, Anniina Snellman, Olena Shatillo, Paula Lehtiniemi, Tove J. Grönroos, Päivi Marjamäki, William Trigg, Paul A. Jones, Olof H. Solin, Asla Pitkänen et al. · 2016 · Journal of Nuclear Medicine
  91. Are migraine and non‐migrainous headache risk factors for stroke in the elderly? Findings from a 12‐year cohort follow‐up
    Joanna L. Norton, Florence Portet, Audrey Gabelle, Stéphanie Debette, Karen A. Ritchie, Jacques Touchon, Claudine Berr · 2016 · European Journal of Neurology
  92. The persistent effects of novelty-seeking traits on comparative economic development
    Erkan Gören · 2017 · Journal of Development Economics
  93. Factors Related to Unemployment in Europe. A Cross-Sectional Study from the COURAGE Survey in Finland, Poland and Spain
    Matilde Leonardi, Davide Guido, Rui M.M. Quintas, Fabiola Silvaggi, Erika Guastafierro, Andrea Martinuzzi, Somnath Chatterji, Seppo V. P. Koskinen, Beata Tobiasz‐Adamczyk, Josep Maria Haro et al. · 2018 · International Journal of Environmental Research and Public Health
  94. An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care
    Reinier Luuk Sluiter, Joost Janzing, Gert Jan van der Wilt, Wietske Kievit, Martina Teichert · 2019 · The Pharmacogenomics Journal
  95. Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan.
    Chia Te Liao, M C Lee, Zhih‐Cherng Chen, Li‐Jung Elizabeth Ku, Jung‐Der Wang, Han Siong Toh · 2020 · PubMed Central
  96. Renal dysfunction and long-term risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting
    Martin J. Holzmann, Erik Ahlbäck, Anders Jeppsson, Ulrik Sartipy · 2012 · International Journal of Cardiology
  97. Management of focal epilepsy in adults treated with polytherapy in France: The direct cost of drug resistance (ESPERA study)
    Marie de Zélicourt, Bertrand de Toffol, Hervé Vespignani, C. Laurendeau, Laurie Lévy-Bachelot, Cahuê De Bernardis Murat, Francis Fagnani · 2014 · Seizure
  98. Engraftment of enteric neural progenitor cells into the injured adult brain
    Jaime Belkind‐Gerson, Ryo Hotta, Michael J. Whalen, Naema Nayyar, Nándor Nagy, Lily S. Cheng, Aaron Zuckerman, Allan M. Goldstein, Jörg Dietrich · 2016 · BMC Neuroscience
  99. Quality of Life in Parkinson’s Disease – Patient, Clinical and Research Perspectives
    Fabrizio Stocchi, Pablo Martínez‐Martín, Heinz Reichmann · 2014 · European Neurological Review
  100. Low emotion-oriented coping and informal help-seeking behaviour as major predictive factors for improvement in major depression at 5-year follow-up in the adult community
    Stephanie Rodgers, Caroline Louise Vandeleur, Marie‐Pierre F. Strippoli, Enrique Castelao, Anja Tesic, Jennifer Glaus, Aurélie M. Lasserre, Mario Müller, Wulf Rössler A, Vladeta Ajdacic‐Gross et al. · 2017 · Social Psychiatry and Psychiatric Epidemiology